Peripheral Neuropathy Trial, Recruiting NCT07461896 Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07461896
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have a genetically confirmed diagnosis of one of the following types of Charcot-Marie-Tooth disease (CMT): CMT1A, CMT1B, CMTX1, CMT2I/J, CMT4B, CMT4D, or CMT4J
  • People who have a clinical diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (a condition where the immune system damages the nerves) or anti-MAG polyneuropathy (a nerve condition linked to certain immune proteins)

Who may not be able to join:

  • People whose nerve problems are known to be caused by something else, such as diabetes, kidney disease, medications, or alcohol — or who have had surgery for carpal tunnel syndrome
  • People who have been treated with certain chemotherapy drugs or other medications known to cause nerve damage, or who currently have a serious problem with alcohol use
  • People who have been diagnosed with cancer (other than skin cancer) within the last 5 years before joining the trial
  • People who are currently pregnant or breastfeeding
  • People who have a known medical condition affecting the whole body that is linked to nerve damage
  • People who have other diseases affecting the brain or spinal cord

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Davide Pareyson, MD, Fondazione IRCCS Istituto Neurologico Carlo Besta

Phone: + 39 02.2394

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Registry
ClinicalTrials.gov
Start date
3 March 2025
Est. completion
1 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Strength-Duration Time Constant; Recovery Cycle of Nerve Excitability Parameters; Threshold Electrotonus; Current-Threshold (I/V) Relationship

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov